Famotidine
| Helehelena | Keʻokeʻo i mae keʻokeʻo melemele keʻokeʻo |
| Solubility | Hoʻokuʻu wale ʻia i dimethylform-amide a i glacial acetic acid; soluble iki i ka methanol; soluble iki i ka wai; hiki ʻole ke hoʻopau ʻia i ka acetone, i ka wai ʻona, i ka chloroform, i ka ether, a i ka ethyl acetate. |
| ʻIlika | ʻIke Heli: |
| ʻO Consist me ka hōʻike i loaʻa me Famotidine CRS. | |
| Mea Pono Pili | Pākuʻi e pili ana B .30.3% |
| Pākuʻi e pili pū ana ≤0.3% | |
| Pākuʻi e pili pū ana ≤0.3% | |
| Pākuʻi e pili pū ana ≤0.3% | |
| Pākuʻi pili F ≤0.1% | |
| Cyanoamidine ≤0.2% | |
| Amidine ≤0.2% | |
| Kekahi haumia ʻē aʻe ≤0.1% | |
| Huina haumia≤ 1.0% | |
| Lilo ma ka hoʻomaloʻo ʻana | ≤0.5% |
| .Residue ma Ignition | ≤0.1% |
| Nā metala kaumaha | ≤10ppm |
| Nā mea hoʻoheheʻe koena | ʻO Ethanol≤0.5% |
| Acetone≤0.5% | |
| Assay | ≥98.5% |
| Launch | Loaʻa iā ia he apo thiazole a loaʻa kahi hopena inhibitory ikaika i ka huna acid gastric. ʻO ka lōʻihi o ka hana ka lōʻihi loa i kēia papa o nā lāʻau. ʻAʻohe anti-androgen a me ka pāpā ʻana o nā enzyme metabolic. Hiki i ka Famotidine ke kāohi i ka hoʻoliʻiliʻi o ka ʻike glycoprotein i loko o ka mucosa gastric o nāʻiole i hoʻokomo ʻia e ke koʻikoʻi, a hiki i ka hoʻomau hoʻomau ʻana ke hāpai i ka hoʻōla o nā maʻi maʻi maʻi mau. ʻO nā hoʻokolohua hoʻohālikelike ʻelua makapō i nā hoʻokolohua holoholona a me ke kahe o ke kahe o gastrointestinal i hōʻike ʻia he hopena hemostatic ka famotidine. Loaʻa ka hopena o kēia huahana i ka pale ʻana i nā hana mucosal gastric hoʻokolohua a me ka hoʻonui ʻana i ke kahe o ke koko o ka mucosa gastric. ʻAʻole hoʻololi kēia huahana i ka uku o ka haʻalele ʻana o ka gastric, ʻaʻole ia e hoʻopilikia i ka hana pancreatic, ʻaʻohe teratogenike, carcinogenic, pāpā ʻana i nā enzymes lāʻau ate a me ka pāpā o androgen. |
Kākau i kāu leka ma aneʻi a hoʻouna iā mākou
